Tests took 6 weeks and destroyed tissue. AI now analyzes digital slides in 2 days, preserving samples for future care.
A personalized cancer diagnostics company focused on prostate cancer treatment, serving a patient population where over 300,000 Americans are diagnosed annually.
Traditional genomic tests rely on chemical assays that take six weeks to process and destroy the original tissue sample. This delay forces patients...
“Artera was founded with the belief that there were a lot of signals in the histopathology image data that were not being used, but if an AI algorithm could be specifically developed with this mind, you could radically change cancer patient care.”
Multimodal AI platform for personalized cancer therapy and clinical diagnostics.
Cloud computing platform and on-demand infrastructure services.
Related implementations across industries and use cases
CPU bottlenecks delayed urgent post-surgery biopsies. GPU-accelerated pipelines now empower lab teams to meet strict delivery targets.
Researchers spent months scouring medical literature. GenAI now mines insights in minutes, accelerating cancer test development.
Experts manually sifted 100k cases. Now, AI parses literature and highlights source text, speeding up time-sensitive diagnoses.
Nurses manually reviewed charts for risk. AI now automates stratification, launching a diagnostic tool in 12 months vs years.
Clinicians spent hours manually tracing anatomy. AI now automates segmentation, cutting planning time by 47% to scale care.
Attorneys juggled fragmented tools to search 50,000 cases. An AI orchestrator now routes queries to sub-agents in a single chat.
Scattered data slowed prep for 15-minute visits. AI now fuses insights into instant briefs, saving reps one full day of admin weekly.
Analyzing 10TB of weekly telemetry took IT specialists days. Now, engineers ask AI in natural language to instantly retrieve charts.
Custom hardware bottlenecked imaging. A switch to software-defined GPUs now renders photorealistic 3D hearts in real time.